210 related articles for article (PubMed ID: 38484445)
1. Advances in self-assembled nanotechnology in tumor therapy.
Kuang Y; Li Z; Chen H; Wang X; Wen Y; Chen J
Colloids Surf B Biointerfaces; 2024 May; 237():113838. PubMed ID: 38484445
[TBL] [Abstract][Full Text] [Related]
2. Carrier-Free Nanomedicine for Cancer Immunotherapy.
Fu Y; Bian X; Li P; Huang Y; Li C
J Biomed Nanotechnol; 2022 Apr; 18(4):939-956. PubMed ID: 35854464
[TBL] [Abstract][Full Text] [Related]
3. Taxanes prodrug-based nanomedicines for cancer therapy.
Sun L; Zhao P; Chen M; Leng J; Luan Y; Du B; Yang J; Yang Y; Rong R
J Control Release; 2022 Aug; 348():672-691. PubMed ID: 35691501
[TBL] [Abstract][Full Text] [Related]
4. Cancer nanomedicine: focus on recent developments and self-assembled peptide nanocarriers.
Raza F; Zafar H; You X; Khan A; Wu J; Ge L
J Mater Chem B; 2019 Dec; 7(48):7639-7655. PubMed ID: 31746934
[TBL] [Abstract][Full Text] [Related]
5. Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives.
Ali ES; Sharker SM; Islam MT; Khan IN; Shaw S; Rahman MA; Uddin SJ; Shill MC; Rehman S; Das N; Ahmad S; Shilpi JA; Tripathi S; Mishra SK; Mubarak MS
Semin Cancer Biol; 2021 Feb; 69():52-68. PubMed ID: 32014609
[TBL] [Abstract][Full Text] [Related]
6. The Phe-Phe Motif for Peptide Self-Assembly in Nanomedicine.
Marchesan S; Vargiu AV; Styan KE
Molecules; 2015 Nov; 20(11):19775-88. PubMed ID: 26540034
[TBL] [Abstract][Full Text] [Related]
7. Artificial intelligence aids in development of nanomedicines for cancer management.
Tan P; Chen X; Zhang H; Wei Q; Luo K
Semin Cancer Biol; 2023 Feb; 89():61-75. PubMed ID: 36682438
[TBL] [Abstract][Full Text] [Related]
8. Multistage Self-Assembled Nanomaterials for Cancer Immunotherapy.
Guo L; Yang J; Wang H; Yi Y
Molecules; 2023 Nov; 28(23):. PubMed ID: 38067480
[TBL] [Abstract][Full Text] [Related]
9. Bridging Bio-Nano Science and Cancer Nanomedicine.
Björnmalm M; Thurecht KJ; Michael M; Scott AM; Caruso F
ACS Nano; 2017 Oct; 11(10):9594-9613. PubMed ID: 28926225
[TBL] [Abstract][Full Text] [Related]
10. Self-assembled polymeric vesicles: Focus on polymersomes in cancer treatment.
Araste F; Aliabadi A; Abnous K; Taghdisi SM; Ramezani M; Alibolandi M
J Control Release; 2021 Feb; 330():502-528. PubMed ID: 33358973
[TBL] [Abstract][Full Text] [Related]
11. Multifunctional Cargo-Free Nanomedicine for Cancer Therapy.
Wang Y; Yang P; Zhao X; Gao D; Sun N; Tian Z; Ma T; Yang Z
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30274177
[TBL] [Abstract][Full Text] [Related]
12. Nanotechnology: Revolutionizing the Science of Drug Delivery.
Mishra M; Kumar P; Rajawat JS; Malik R; Sharma G; Modgil A
Curr Pharm Des; 2018; 24(43):5086-5107. PubMed ID: 30727873
[TBL] [Abstract][Full Text] [Related]
13. Organoids technology for advancing the clinical translation of cancer nanomedicine.
Zhao DK; Liang J; Huang XY; Shen S; Wang J
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(5):e1892. PubMed ID: 37088100
[TBL] [Abstract][Full Text] [Related]
14. Minimally invasive nanomedicine: nanotechnology in photo-/ultrasound-/radiation-/magnetism-mediated therapy and imaging.
Ouyang J; Xie A; Zhou J; Liu R; Wang L; Liu H; Kong N; Tao W
Chem Soc Rev; 2022 Jun; 51(12):4996-5041. PubMed ID: 35616098
[TBL] [Abstract][Full Text] [Related]
15. Inflammation targeted nanomedicines: Patents and applications in cancer therapy.
Praveen TK; Gangadharappa HV; Abu Lila AS; Moin A; Mehmood K; Krishna KL; Hussain T; Alafnan A; Shakil S; Rizvi SMD
Semin Cancer Biol; 2022 Nov; 86(Pt 2):645-663. PubMed ID: 35405339
[TBL] [Abstract][Full Text] [Related]
16. Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy?
Kateb B; Chiu K; Black KL; Yamamoto V; Khalsa B; Ljubimova JY; Ding H; Patil R; Portilla-Arias JA; Modo M; Moore DF; Farahani K; Okun MS; Prakash N; Neman J; Ahdoot D; Grundfest W; Nikzad S; Heiss JD
Neuroimage; 2011 Jan; 54 Suppl 1(Suppl 1):S106-24. PubMed ID: 20149882
[TBL] [Abstract][Full Text] [Related]
17. Polyprodrug Nanomedicines: An Emerging Paradigm for Cancer Therapy.
Yang K; Yang Z; Yu G; Nie Z; Wang R; Chen X
Adv Mater; 2022 Feb; 34(6):e2107434. PubMed ID: 34693571
[TBL] [Abstract][Full Text] [Related]
18. Challenges and Opportunities from Basic Cancer Biology for Nanomedicine for Targeted Drug Delivery.
Xie X; Zhang Y; Li F; Lv T; Li Z; Chen H; Jia L; Gao Y
Curr Cancer Drug Targets; 2019; 19(4):257-276. PubMed ID: 29956629
[TBL] [Abstract][Full Text] [Related]
19. Implications of nanotechnology for the treatment of cancer: Recent advances.
Klochkov SG; Neganova ME; Nikolenko VN; Chen K; Somasundaram SG; Kirkland CE; Aliev G
Semin Cancer Biol; 2021 Feb; 69():190-199. PubMed ID: 31446004
[TBL] [Abstract][Full Text] [Related]
20. Nano based drug delivery systems: recent developments and future prospects.
Patra JK; Das G; Fraceto LF; Campos EVR; Rodriguez-Torres MDP; Acosta-Torres LS; Diaz-Torres LA; Grillo R; Swamy MK; Sharma S; Habtemariam S; Shin HS
J Nanobiotechnology; 2018 Sep; 16(1):71. PubMed ID: 30231877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
